Adamis Pharmaceuticals (ADMP) Open to New Partnerships for EpiPen Alternative; Targets New NDA Submission by Year End - Bloomberg
Get access to the best calls on Wall Street with StreetInsider.com's Ratings Insider Elite. Get your Free Trial here.
Adamis Pharmaceuticals (NASDAQ: ADMP) Open to New Partnerships for EpiPen Alternative; Targets New NDA Submission by Year End - Bloomberg
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- DragonWave (DRWI) Says Trials with Harmony Enhanced MC Resulted in Multiple Order Activity and Demand
- First NBC Bank (FNBC) Disagrees with 'Unfounded Assertions' in the Market
- Amyris (AMRS) Executes Definitive Agreements with Nutraceuticals Partner; Includes Strategic Investment, Credit Facility